As elec­tion storm gath­ered, Ar­row­head drops word about a clin­i­cal hold

As every­one’s at­ten­tion was be­ing com­mand­ed by the big pres­i­den­tial vote Tues­day night, Ar­row­head Phar­ma­ceu­ti­cals $AR­WR chose to put out word that its lead pro­gram …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER